Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAC-LC/MS Detection of Exogenous Growth Hormone in Healthy Men
jRCTs031220120Completed
- Sponsor
- World Anti-Doping Agency
- Start
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of somatropin (2 arms), sponsored by World Anti-Doping Agency. Primary endpoint: Serum/plasma growth hormone concentrations. Started Mar 2024; status: completed.
02
Drugs
somatropin
Beyond the preview
Go deeper on jRCTs031220120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220120.